TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 41 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $288,000 | -26.2% | 1,248,831 | +14.8% | 0.00% | – |
| Q4 2021 | $390,000 | -26.6% | 1,087,732 | +23.4% | 0.00% | – |
| Q3 2021 | $531,000 | -41.6% | 881,734 | +7.7% | 0.00% | – |
| Q2 2021 | $909,000 | +461.1% | 818,869 | +548.5% | 0.00% | – |
| Q1 2021 | $162,000 | +161.3% | 126,272 | +38.6% | 0.00% | – |
| Q4 2020 | $62,000 | -19.5% | 91,097 | 0.0% | 0.00% | – |
| Q3 2020 | $77,000 | – | 91,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 734,477 | $441,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 516,218 | $310,000 | 0.03% |
| Game Plan Financial Advisors, LLC | 27,216 | $16,000 | 0.01% |
| MONECO Advisors, LLC | 35,000 | $21,000 | 0.01% |
| Purus Wealth Management, LLC | 15,000 | $9,000 | 0.01% |
| Renaissance Technologies | 6,038,664 | $3,630,000 | 0.01% |
| Qube Research & Technologies Ltd | 540,878 | $325,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 6,690,867 | $4,022,000 | 0.00% |
| Cutter & CO Brokerage, Inc. | 19,000 | $11,000 | 0.00% |
| Van Hulzen Asset Management, LLC | 18,200 | $11,000 | 0.00% |